Pharmafile Logo

The Clinical Trial Company

The Clinical Trial Company (TCTC) targets medium size clinical trials and novel products which lack a classical road map to the market.
Large CROs prioritise studies from the big pharma companies, for good business reasons. However, this approach sometimes disadvantages their SME clients who are equally keen to complete their clinical trials quickly. TCTC are experts in advanced therapies, such as cell and gene therapies, as well as orphan drug and biologics.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Company Details

Mere View Barn, Park Lane, Pickmere, Knutsford, WA16 0LG, UK
+44 1565 733 772

 Latest Content from PMHub 

Inizio leaders featured in Forbes’ ‘Voices of Oncology’ to drive innovation in cancer care

Press Releases | September 24, 2025 | Inizio

Inizio experts contribute to Forbes’ Voices of Oncology, highlighting our commitment to driving innovation in cancer care through advanced data analytics, cross-sector collaboration, and real-world impact for patients.

Breakthrough Alzheimer’s Therapies Drive Early Detection Rates While Exposing Deep Treatment Disparities

Press Releases | September 22, 2025 | Medscape Education

Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...

CMI Media Group and Compas Earn 2025 Great Place To Work Certification

Press Releases | September 19, 2025 | CMI Media Group

PHILADELPHIA, PA – Strategic media healthcare agencies CMI Media Group & Compas, a WPP company (NYSE: WPP), are proud to be Certified™ by Great Place To Work® for the third year in...

solli – CMI’s International Man of Media

Press Releases | September 19, 2025 | CMI Media Group

Matt Durham, VP, Global, anticipated pharma’s global media boom. Now he’s leading CMI Media Group’s push to broaden its market coverage. This new profile article focusing on Global VP Matt...

PharmiWeb – Why Pharmaceutical Brands Must Act On Digital Trends Now

Press Releases | September 19, 2025 | CMI Media Group

The ASCO Conference has a global impact; a new PharmiWeb byline by Calum Griffin, Senior Global Engagement Planner inspired by the conference shares that the pharma marketing landscape has radically...

Genetic Digital Wins Silver at PM Society Digital Awards for Epilepsy Meds Clinical Support App

Press Releases | September 18, 2025 | Genetic Digital

Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.

AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation

Press Releases | September 17, 2025 | Innovative Trials

Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK

Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences

Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid...

Streamlining European expansion for cell and gene therapies

White Papers and Resources | September 16, 2025 | Uniphar

Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for commercial success in Europe’s unique market when developing cell and gene therapies (CGTs). Europe...

Current CGT landscape and future outlook  

White Papers and Resources | September 16, 2025 | Uniphar

What makes CGT unique  Cell and gene therapy (CGT) is a unique treatment that uses cells and genetic material to treat and cure diseases. Personalized to the patient, CGT’s offer...